Xiaobing Wang | Biochemistry | Best Researcher Award

Published on by China Scientist

Prof. Xiaobing Wang | Biochemistry | Best Researcher Award

Leadership in Academia:

  • Wang’s progression from Lecturer to Associate Professor and finally to full Professor reflects his leadership and dedication to advancing the field of natural medicinal chemistry. His mentorship of students and research initiatives further strengthens his academic standing.

Prof. Xiaobing Wang | China Pharmaceutical University | China

Author Profile

SCOPUS ID

ORCID ID

 🎓EARLY ACADEMIC PURSUITS:

  • Dr. Xiaobing Wang’s academic foundation is rooted in his Bachelor of Science in Chemistry Education from Hanzhong Teachers College, completed in 2001. Here, he developed essential skills in chemistry, complemented by proficiency in tools like MS Office and Photoshop. His academic journey progressed to Shaanxi Normal University, where he earned his Master’s degree in Organic Chemistry in 2005. Under the mentorship of Professor Zun-Ting Zhang, he conducted detailed research on the crystal structure and supramolecular forces of isoflavonoids, laying the groundwork for his expertise in molecular structures. His academic trajectory reached its pinnacle at China Pharmaceutical University, where he earned a Ph.D. in Medicinal Chemistry in 2008. Guided by Professor Ling-Yi Kong, his doctoral research focused on the design, synthesis, and structure-activity relationship (SAR) studies of N-containing flavonoid analogues, showcasing his adeptness in computational and synthetic chemistry.

 🏥 Professional Milestones:

  • Dr. Wang’s professional journey is a testament to his dedication to medicinal chemistry. Since joining China Pharmaceutical University in 2008, he has progressed through key academic roles, beginning as a Lecturer of Medicinal Chemistry. In 2011, he was promoted to Associate Professor, where he expanded his contributions to organic synthesis and computational methodologies. By 2017, he attained the rank of Professor of Natural Medicinal Chemistry, leading significant projects at the State Key Laboratory of Natural Medicines. His career also includes international exposure as a research scholar at The Scripps Research Institute, where he worked under Prof. Jin-Quan Yu, further refining his expertise in modern synthetic methodologies.

🧬 Research Contributions:

  • Dr. Wang’s research focuses on the innovative intersection of natural medicinal chemistry and computational approaches. His expertise in organic synthesis has driven the design of novel flavonoid analogues with potential therapeutic applications. With advanced proficiency in computational chemistry tools such as MOE, Discovery Studio, Gaussian, and AutoDOCK, he has developed cutting-edge drug modeling and docking techniques. His deep understanding of analytical methods, including LC-MS and NMR spectroscopy, has been instrumental in validating molecular structures. Additionally, his work on SAR studies has contributed to optimizing drug efficacy and safety, solidifying his reputation as a pioneer in the field of medicinal chemistry.

🌍 IMPACT AND INFLUENCE

  • Dr. Wang’s influence extends beyond his research. As a teacher and mentor, he has inspired countless students, equipping them with the skills and knowledge needed to excel in medicinal chemistry. His interdisciplinary approach, combining computational tools with experimental techniques, has set a benchmark for modern drug discovery. Through collaborations and international research exchanges, he has significantly advanced the development of natural product-based pharmaceuticals, reinforcing the importance of sustainable and innovative approaches in medicinal chemistry.

📊 ACADEMIC CITATIONS

  • Dr. Wang’s scholarly contributions have been widely recognized in the academic community. His research is frequently cited in high-impact journals, reflecting the significance of his work in advancing medicinal chemistry. His academic identifiers, including Researcher ID: H-1541-2011 and ORCID: 0000-0001-5044-3721, underscore his active engagement with the global research community and his dedication to maintaining the highest standards in scholarly publishing.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Wang’s legacy is defined by his commitment to advancing medicinal chemistry through innovation, research, and mentorship. His future endeavors aim to further explore natural product-based drug discovery, focusing on eco-friendly and sustainable synthetic methodologies. He envisions expanding the therapeutic applications of flavonoid analogues and fostering collaborative research efforts to address pressing challenges in pharmaceutical sciences. His work will undoubtedly continue to shape the field, leaving a lasting impact on both academia and industry.

📄Publications

  • Copper(II)/Rhodium(III)-Catalyzed Three-Component Sequential Annulation-Olefination of 2-Arylquinoxalines
    • Authors: Chen, Y., Yin, F., Luo, Z., … Kong, L., Wang, X.
    • Journal: European Journal of Organic Chemistry, 2024, 27(44), e202400717
  • Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis
    • Authors: Li, S., Ma, L., Li, X., … Kong, L., Wang, X.
    • Journal: Journal of Medicinal Chemistry, 2024, 67(17), pp. 15353–15372
  • Corrigendum to “Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer’s disease”
    • Authors: Tang, Y.-W., Shi, C.-J., Yang, H.-L., … Kong, L.-Y., Wang, X.-B.
    • Journal: European Journal of Medicinal Chemistry, 2024, 275, 116591
  • Stereoselective Synthesis of β, γ-Fused Bicyclic γ-Ureasultams via an Intramolecular Mannich and aza-Michael Addition Cascade
    • Authors: Yin, F., Qu, L., Chen, Y., … Kong, L., Wang, X.
    • Journal: Chemistry – A European Journal, 2024, 30(28), e202400438
  • Improving tumor sensitivity by the introduction of an ester chain to triaryl derivatives targeting PD-1/PD-L1
    • Authors: Zhang, Y., Yin, F., Luo, Z., … Kong, L., Wang, X.
    • Journal: European Journal of Medicinal Chemistry, 2024, 271, 116433

Le Ma | Pharmacology | Best Researcher Award

Published on by China Scientist

Dr. Le Ma | Pharmacology | Best Researcher Award

Patents and Future Innovations:

  • With three patents under process, his work bridges research and practical innovation, indicating a strong focus on translational science.

Author Profile

SCOPUS ID

Mr. Pei Yang |Shanghai Mental Health Center | China

 🎓EARLY ACADEMIC PURSUITS:

  • Le Ma pursued his medical doctorate at the School of Pharmacy, Shanghai Jiao Tong University. During his studies, he focused on fundamental and clinical research in neuropsychopharmacology, laying a solid foundation for his future contributions to the field of pain management and pharmacology.

 🏥 Professional Milestones:

  • After earning his doctorate, Le Ma joined the Shanghai Mental Health Center at Shanghai Jiao Tong University School of Medicine in July 2022. His work there included groundbreaking research on pain mechanisms, highlighted by his role as a corresponding author in significant publications. His efforts were recognized by Wiley China Open Science, earning him the title of High-Contribution Author.

🧬 Research Contributions:

  • Le Ma’s primary research revolves around pain and pharmacology, with a particular emphasis on:
    1. The role of store-operated calcium channels in pain progression.
    2. Mechanisms of analgesic drug efficacy, particularly those derived from Chinese herbal medicines.
    3. Development of biomarkers for pain assessment, including glycolytic metabolites and mitochondrial homeostasis.

🌍 IMPACT AND INFLUENCE

  • Le Ma’s work has had a profound impact on pain management, with 16 published papers in high-impact journals such as FEBS Open Bio and Phytomedicine. His innovative studies have advanced our understanding of pain biomarkers and therapeutic targets, influencing clinical approaches to pain treatment globally.

📊 ACADEMIC CITATIONS

  • Le Ma’s research contributions have garnered 106 citations, reflecting the academic community’s recognition of his impactful work in neuropsychopharmacology.

🏅 AWARDS AND RECOGNITIONS

  • Le Ma’s exceptional contributions to neuropsychopharmacology have been acknowledged through 12 prestigious academic awards. His expertise and innovative research have also earned him invitations to participate in 12 academic exchanges, both domestically and internationally, showcasing his leadership and influence in the scientific community.

🧬 MEMBERSHIPS AND AFFILIATIONS

  • As a committed member of the Shanghai Pharmaceutical Association, Le Ma actively contributes to advancing the field of pharmacology. His engagement with this professional body underscores his dedication to fostering collaboration and innovation within the pharmaceutical sciences.

🚀 FUTURE ASPIRATIONS

  • Le Ma envisions bridging the gap between fundamental research and clinical applications by focusing on pain biomarker development and personalized pain management therapies. His future work aims to revolutionize pain assessment and treatment, improving patient outcomes and advancing the field of pharmacology.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

  • Le Ma is poised to further his research through ongoing projects, such as:
    • Investigating mitochondrial homeostasis in astilbin-mediated analgesia.
    • Exploring the succinate-tricarboxylic acid cycle axis as a biomarker for pain.

    With three patents under process and an editorial appointment at the Journal of Neuroimmune Pharmacology, his legacy promises to include both theoretical advancements and practical innovations in pharmacology.

📄Publications

  • Andrographolide exhibits antinociceptive effects in neuropathic rats via inhibiting class Ⅱ MHC associated response and regulating synaptic plasticity
    Authors: Ma, L.; Sun, Y.; Liu, B.; … Chen, J.; Ju, P.
    Journal: Phytomedicine, 2024, 132, 155823
  • Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
    Authors: Wang, Q.; Duan, D.; Luo, C.; … Yang, S.; Ma, L.
    Journal: Annals of Medicine, 2024, 56(1), 2396561
  • Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain
    Authors: Huang, J.; Chen, J.; Ma, L.; … Li, X.; Guo, C.
    Journal: Journal of Pain Research, 2024, 17, pp. 1531–1545
  • Alpha 2-adrenoceptor participates in anti-hyperalgesia by regulating metabolic demand
    Authors: Zhang, K.; Ren, Y.-Q.; Xue, Y.; … Guan, J.-Q.; Ma, L.
    Journal: Frontiers in Pharmacology, 2024, 15, 1359319
  • Metformin Alleviates Pain States by Regulating the Balance of Spinal Synaptic Transmission
    Authors: Duan, D.; Wu, X.; Ali, U.; … Mao, Y.; Ma, Y.
    Journal: Journal of Integrative Neuroscience, 2024, 23(1), 2301006

Pei Yang | Brain Glioma | Best Researcher Award

Published on by China Scientist

Mr. Pei Yang | Brain Glioma | Best Researcher Award

Beijing Tiantan Hospital, Capital Medical University | China

Author Profile

SCOPUS ID

Mr. Pei Yang |Advancing Neurosurgical Research and Care

 🎓 Academic Journey: 

  • Mr. Pei Yang embarked on an illustrious academic career in medicine, beginning with a Bachelor’s degree in Clinical Medicine from Chengde Medical College (2005–2010). She further honed her expertise with a Master’s and PhD in Neurosurgery at Capital Medical University (2010–2016). Her rigorous training laid a strong foundation for her future contributions to neurosurgery and glioma research.

 🏥 Professional Milestones:

  • Since joining the Beijing Neurosurgery Institute, Mr. Yang has steadily progressed, currently serving as an Associate Chief Physician (2022–present). Her prior roles as an Attending Physician (2019–2021) and Physician (2016–2018) reflect her relentless pursuit of excellence in patient care and medical innovation. Her work focuses on glioma pathology and neurosurgical advancements, positively impacting patients and the field alike.

🧬 Research Contributions:

  • Mr. Yang’s research is at the cutting edge of understanding brain tumors, particularly gliomas. Her work delves into mechanisms such as the c-MET/E2F1/DMC1 signaling pathway and its role in chemotherapy resistance. Notably, she has successfully completed a National Natural Science Foundation of China project investigating this pathway’s impact on DNA repair. Additionally, her ongoing project on terahertz time-domain spectroscopy in glioma diagnosis highlights her innovative approach to integrating technology with medicine.

📜 Academic Publications:

  • Mr. Yang has authored numerous impactful publications in esteemed journals. Among her key works are:
    • A study on a nine-gene signature in gliomas (Clinical Immunology, 2020), where she served as a co-corresponding author.
    • Research into the immunosuppressive roles of VAT1 expression in diffuse gliomas (Cancer Immunology, Immunotherapy, 2021), for which she was the sole first author.
    • Investigations into terahertz spectral applications in glioma pathology (Spectrochimica Acta Part A, 2023), emphasizing her role as a co-corresponding author.

    These publications highlight her ability to translate complex findings into meaningful contributions for both academia and clinical practice.

🌟 Vision for the Future: 

  • With ongoing projects exploring cutting-edge methodologies, such as terahertz spectroscopy and the prediction of glioma mutations, Mr. Yang is determined to revolutionize glioma diagnostics and treatment. Her dedication to neurosurgical research, combined with a passion for patient care, positions her as a trailblazer in the field.

🏅 Recognitions and Beyond:

  • Though not yet formally awarded for her academic and clinical achievements, Mr. Yang’s influence is evident through her leadership roles in pioneering research and her commitment to nurturing the next generation of medical professionals.

📄Publications

  • Ensemble learning prediction framework for EGFR amplification status of glioma based on terahertz spectral features
    • Authors: Wu, X., Tao, R., Sun, Z., Zhao, X., Yang, P.
    • Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy, 2024, 316, 124351
  • Prediction of IDH mutation status of glioma based on terahertz spectral data
    • Authors: Sun, Z., Wu, X., Tao, R., Zhang, Z., Yang, P.
    • Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy, 2023, 295, 122629
  • Biomedical applications of terahertz spectra in clinical and molecular pathology of human glioma
    • Authors: Wu, X., Tao, R., Zhang, T., Zhao, X., Yang, P.
    • Journal: Spectrochimica Acta – Part A: Molecular and Biomolecular Spectroscopy, 2023, 285, 121933
  • Diagnosing ATRX status in glioma utilizing terahertz spectroscopy and deep learning algorithms
    • Authors: Wu, X., Tao, R., Sun, Z., Zhaoa, X., Yang, P.
    • Journal: Proceedings of SPIE – The International Society for Optical Engineering, 2023, 12960, 129600P
  • Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma
    • Authors: Zhong, L., Yang, P., Zhang, C., Shan, X., Qiu, X.
    • Journal: Chinese Neurosurgical Journal, 2022, 8(1), 6

Hongbo Cai | Digital Economics | Best Researcher Award

Published on by China Scientist

Prof Dr. Hongbo Cai | Digital Economics | Best Researcher Award

Business School, Beijing Normal University | China

Author Profile

SCOPUS ID

🏛️ EARLY ACADEMIC PURSUITS

  • Hongbo Cai began his academic journey at Fuzhou University, where he earned his Bachelor’s degree in Economics in 2004. His growing interest in economics led him to pursue a Ph.D. in Economics at Xiamen University (2004–2009). During his doctoral studies, Hongbo focused on developing an in-depth understanding of international trade, labor economics, and environmental economics, setting the foundation for his future research excellence.

🌟 PROFESSIONAL ENDEAVORS

  • Assistant Professor at the Business School, Beijing Normal University (2009–2013).
  • Associate Professor (2013–2018).
  • Professor (2018–present).
  • Served as Vice Dean of the Business School (2019–2024).
  • Currently the Director of the Financial Office (since December 2023).

In his academic career, Cai has demonstrated exceptional leadership and contributed significantly to the advancement of the Business School at Beijing Normal University.

📊 RESEARCH FOCUS

Hongbo Cai’s research spans several interconnected areas:

  • International Trade: Investigating globalization, trade policies, and their impacts.
  • Digital Economics: Exploring the relationship between technology and economic transformation.
  • Labor Economics: Studying competition in labor markets, wage structures, and employer concentration.
  • Environmental Economics: Analyzing pollution reduction strategies, sustainability pathways, and the influence of infrastructure upgrades on firm behavior.

🌍 IMPACT AND INFLUENCE

  • Hongbo Cai’s work has significantly impacted both academic and policy discussions. His publications have appeared in prestigious journals such as Journal of World Business, British Journal of Management, and China Economic Review, addressing critical global and domestic issues like urban pollution, labor market dynamics, and digital transformation.

Key Achievements:

  • His research on migrants and exports (2021) sheds light on how migration contributes to trade.
  • The 2024 study on employee ownership and firm digital transformation links organizational structures to technological advancements.
  • His investigation into urban openness and sustainability offers actionable insights for policymakers aiming to reduce pollution.

🔬 CONTRIBUTIONS TO RESEARCH

  Notable Projects

  • National Social Science Fund of China (Major Project): Research on significant economic transformations (2022–2024).
  • China National Natural Science Foundation Projects: Multiple funded studies focusing on digital economics, environmental economics, and trade.

  Key Articles in Chinese Journals

  • Insights into digital technology applications and export performance (Management World, 2024).
  • Evaluation of firm relocation and environmental impacts (Economic Research, 2022).

📚 ACADEMIC CITATIONS

  • With a robust portfolio of highly cited works, Cai’s research continues to influence academics and professionals worldwide. His studies have contributed to the development of policy frameworks and theoretical advancements in economics.

🎯 LEGACY AND FUTURE CONTRIBUTIONS

  • As a scholar and leader, Hongbo Cai has made an indelible mark in economics, particularly in integrating digital transformation and sustainability into economic discourse.

   Future Directions:

  • Further exploration of digital trade dynamics.
  • Strategies for balancing economic growth with environmental sustainability.
  • Continued mentorship to foster a new generation of economists at Beijing Normal University.

🏆 CONCLUDING REMARKS

  • Hongbo Cai exemplifies academic excellence, combining impactful research with dedicated service to academia and society. His legacy is a testament to his unwavering commitment to advancing knowledge in economics and influencing real-world outcomes.

📄Publications

  • “Unveiling the Green Path: How Urban Openness Reduces Pollution and Paves the Way to Sustainability”
    Authors: Zhong, C., Cai, H., Liu, L., Xue, R., Shan, Y.
    Journal: Journal of Environmental Management, 2024, Vol. 370, Article 122378.
  • “Administrative Division Adjustment and Environmental Pollution: Evidence from City-County Mergers in China”
    Authors: Ma, H., Zou, J., Cai, H., Zhang, L.
    Journal: China Economic Review, 2024, Vol. 84, Article 102141.
  • “Employee Ownership and Firm Digital Transformation”
    Authors: Dong, M., Choi, Y., Ma, P., Cai, H., Cui, L.
    Journal: British Journal of Management, 2024 (In Press).
  • “Competition in the Labor Market: The Wage Effect of Employer Concentration in China”
    Authors: Liu, J., Cai, H., Lin, C.
    Journal: Industrial Relations: A Journal of Economy and Society, 2024 (In Press).
  • “A New Look at the Remittances-FDI-Energy-Environment Nexus in the Case of Selected Asian Nations”
    Authors: Rahman, Z.U., Cai, H., Ahmad, M.
    Journal: Singapore Economic Review, 2023, Vol. 68(1), pp. 157–175.

Assist Prof Dr. Iong Man Teng | Medical Law | Best Researcher Award

Published on by China Scientist

Assist Prof Dr. Iong Man Teng | Medical Law | Best Researcher Award

 Faculty of Law of the University of Macau | China

Author Profile

SCOPUS ID

ORCID ID

GOOGLE SCHOLAR

🌟 Assist Prof Dr. Iong Man Teng: A Dedicated Scholar in Law and Healthcare 📚⚖️

🌿Professional Title:

Assistant Professor and Programme Coordinator of Master of Law in Macau Law and Practice, Faculty of Law, University of Macau

🖥Biography:

Assistant Professor and Programme Coordinator of the Master of Law in Macau Law and Practice at the University of Macau, Dr. Man Teng Iong holds a PhD in Private Law from the University of Minho, Portugal. Specializing in Medical/Health Law and the Law of Obligations, his contributions include groundbreaking studies on traditional Chinese medicine’s civil liability and Advance Directives. He has authored notable works, including Responsabilidade Civil na Medicina Tradicional Chinesa (2024), and serves as an editor for esteemed legal journals while actively collaborating with global research institutions.

🎓Academic Journey:

  • PhD in Private Law, University of Minho, Portugal (2018-2022)
  • Master of Laws, University of Macau, China (2013-2015)
  • Bachelor of Laws, New University of Lisbon, Portugal (2009-2013)

🔬Research Contributions:

  • Dr. Man Teng Iong has profoundly influenced medical and health law through pioneering works. His 2024 publication, Responsabilidade Civil na Medicina Tradicional Chinesa, bridges traditional Chinese medicine and Western legal systems, marking a groundbreaking exploration of civil liability in this field. Additionally, his studies on Advance Directives have expanded the boundaries of patient autonomy, addressing their cross-border and maritime applications.

✒️Editorial Appointments:

  • Associate Editor, Medicine and Law
  • Deputy Chief Editor, China Ocean Law Review
  • Co-Editor in Chief, Marine Law and Policy

🌟Professional Memberships:

  • Vice President of the Macao Association of Promotion of Law for Public
  • Director of Guangzhou Law Society’s Human Rights Law Research Association
  • Vice Chairman of the Macao Think Tank of United Citizens

🌐Collaborations:

  • Dr. Man collaborates extensively, contributing to research at the University of Minho and Hainan University, and represents Macao in the Portuguese-speaking health law association.

🌟Achievements in Academia:

  • With nine journal publications and active participation in leading research centers, Dr. Man Teng Iong continues to foster innovation and cross-cultural dialogue in legal studies.

📘Books Published:

  • Responsabilidade Civil na Medicina Tradicional Chinesa (2024)
  • Directivas Antecipadas de Vontade (2017)
  • Translator of Direito Penal Português – Parte Geral II (2024)

🏥Conclusion:

Dr. Man Teng Iong’s dedication to bridging Eastern and Western legal traditions highlights his commitment to innovation and academic excellence. Through his research, publications, and leadership roles, he continues to shape the discourse on medical law and patient autonomy, fostering greater understanding and global collaboration in the legal domain.

📄Publications

    • “Construction of model contract law for Guangdong-Macao intensive cooperation zone in Hengqin”
      • Author: Iong, M.T.
      • Journal: Journal of Infrastructure, Policy and Development, 2024, 8(4), 3525
    • “The Role of China in Enhancing Global Supply Chains: Legal Obstacles and Solutions”
      • Author: Iong, M.T.
      • Journal: Global Trade and Customs Journal, 2023, 18(9), pp. 338–345
    • “Compulsive medical acts and duty to inform: the Portuguese perspective”
      • Author: Iong, M.T.
      • Journal: BioLaw Journal, 2023, (1), pp. 457–466
    • “Telemedicine in China: An enlightenment from COVID-19”
      • Author: Iong, M.T.
      • Journal: Medicine and Law, 2020, 39(4), pp. 595–602
    • “The struggle against the COVID-19 pandemic in Macao”
      • Authors: Raposo, V.L. and Iong, M.T.
      • Journal: BioLaw Journal, 2020, 2020(Special Issue 1), pp. 747–752

Dr. Tong-jie Yang | Orthopedic Disorders | Young Scientist Award

Published on by China Scientist

Dr. Tong-jie Yang | Orthopedic Disorders | Young Scientist Award

Wangjing Hospital, China Academy of Chinese Medical Sciences | China

Author Profile

ORCID ID

🌟 Dr. Tong-jie Yang: Innovator in Integrative Orthopedics and Traditional Chinese Medicine 🏥

🌿Professional Title:

PhD Candidate in Chinese Medicine | Physician | Researcher in Integrative Orthopedics

🖥Biography:

Dr. Tong-jie Yang is a dynamic researcher and physician advancing the integration of Traditional Chinese Medicine (TCM) with modern orthopedic techniques. Currently pursuing his PhD at the China Academy of Chinese Medical Sciences, he specializes in innovative approaches to musculoskeletal disorders, blending acupuncture, manual therapy, rehabilitation, and imaging-guided treatments. With a Master’s degree in Chinese Orthopedics and a Bachelor’s in Acupuncture and Tuina, Dr. Yang has authored over 11 high-impact academic papers, including SCI publications. His groundbreaking contributions focus on enhancing treatment outcomes for conditions like osteonecrosis and knee arthritis through data modeling and integrative methodologies.

🔬Key Areas of Expertise:

  • 🦵 Traditional Chinese Medicine for Orthopedic Disorders
  • 🎯 Acupuncture & Manual Therapy for Joint Health
  • 🏋️‍♂️ Rehabilitation and Sports Medicine Approaches
  • 🖥 Clinical Applications of Imaging in Orthopedics

🎯Professional Contributions:

  • 📜 Authored 11+ high-impact academic papers
  • 🔬 National research participant in musculoskeletal diseases
  • 🤝 Consultant for Zhejiang University of Traditional Chinese Medicine (2021-2023)

🌟Professional Memberships:

  • 🌐 Chinese Association for the Advancement of Traditional Chinese Medicine
  • 🏅 Beijing Chinese Orthopedic Research Association
  • 🏥 Chinese Society of Social Medicine and Healthcare Management

Dr. Yang’s vision bridges tradition and innovation, shaping the future of orthopedic care with holistic, patient-centered approaches. 🌟

🏥Conclusion:

Dr. Tong-jie Yang is a dedicated scholar and practitioner committed to advancing the integration of Traditional Chinese Medicine with modern orthopedic techniques. Through his innovative research, extensive clinical expertise, and active contributions to the academic community, he continues to enhance treatment outcomes for musculoskeletal disorders. Dr. Yang’s work exemplifies the synergy between traditional healing wisdom and cutting-edge medical advancements, making him a valuable contributor to the future of integrative medicine. 🌿

📄Publications

    1. A Delphi-based Model for Prognosis of Femoral Head Collapse in Osteonecrosis: A Multi-factorial Approach
      • Authors: Tong-jie Yang, Shi-yi Sun, Lei Zhang, Xing-ping Zhang, Hai-jun He
      • Journal: Journal of Orthopaedic Surgery and Research
      • Year: 2024
    1. An Insight of FDA-approved Drugs for the Management of Aging-related Disorders: An In Silico Study
      • Authors: Tong-jie Yang, Quan-qing Wan, Peng-peng Wen
      • Journal: Acta Poloniae Pharmaceutica – Drug Research
      • Year: 2022

Chen Heng | Logistics Economy | Best Researcher Award

Published on by China Scientist

Mr. Chen Heng | Logistics Economy | Best Researcher Award

Research Contributions:

  • He has successfully led over ten significant national, provincial, and departmental projects, including the National Social Science Fund, National Ministry of Education Fund, and other prestigious grants. His projects address critical areas of economics, logistics, and societal challenges, reflecting the impactful nature of his research.
Mr. Chen Heng, Xi’an Polytechnic University, China

Profile

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Chen Heng graduated with a doctoral degree in Applied Economics and a Doctor of Economics from the Department of E-commerce, School of Economics and Finance, Xi’an Jiaotong University. His robust academic background laid a strong foundation for his expertise in applied economics and e-commerce, which he would later integrate into his professional endeavors.

💼PROFESSIONAL ENDEAVORS

  • Chen Heng currently serves as an Associate Professor and Master’s Supervisor at the School of Management, Xi’an Polytechnic University, where he also holds the position of Assistant to the Dean. His additional roles include:
    • Chief Expert of the Emergency Logistics Management Decision-making Consulting Expert Team under the Shaanxi Provincial Association for Science and Technology.
    • Expert Member of the Modern Logistics Industry Chain Science and Technology Innovation Team for the Ankang Municipal Party Committee.
    • Deputy Secretary-General and Executive Director of the Shaanxi Soft Science Research Association.
    • Columnist and commentator for the “Economic Policy” column of the Beijing News.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Chen Heng has presided over more than ten national, provincial, ministerial, and departmental-level projects, including:
    • National Social Science Fund Projects
    • National Ministry of Education Fund Projects
    • Shaanxi Provincial Science and Technology Plan’s Soft Science Research Projects
    • Shaanxi Provincial Social Science Fund
    • Xi’an Municipal Social Science Fund Planning Projects

    His research focuses on emergency logistics management, modern logistics industry development, and economic policy analysis, ensuring that his work bridges practical applications and theoretical advancements.

🌍IMPACT AND INFLUENCE

  • Chen Heng’s research reports have received four endorsements and comments from provincial leaders, highlighting the actionable insights and relevance of his work. He has become a critical voice in economic and logistics policy formulation, contributing to both academic discourse and policy-making processes.

📜 ACADEMIC CITES 

  • Chen Heng has published over 30 papers indexed in SCI, SSCI, and CSSCI journals, reflecting the global recognition of his research contributions. His work continues to influence studies in logistics, economics, and applied policy.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

  • As a high-level talent in Shaanxi Province and a dedicated researcher, Chen Heng’s legacy is shaped by his impactful research, strategic contributions to logistics management, and academic mentorship. Moving forward, his contributions will likely influence emergency logistics innovations and economic policy frameworks, solidifying his role as a thought leader in his fields of expertise.

📄Publications

  • Regional Logistics Industry High-Quality Development Level Measurement, Dynamic Evolution, and Its Impact Path on Industrial Structure Optimization: Finding from China
    Authors: Heng Chen, Yan Zhang
    Journal: Sustainability

Chunbo Li | Gynecology | Best Researcher Award

Published on by China Scientist

 Dr. Chunbo Li | Gynecology | Best Researcher Award

Research Contributions:

  • Dr. Li has been actively involved in multiple research projects funded by the National Natural Science Foundation of China and other prestigious organizations. These include studies on the effects of PM2.5 exposure during pregnancy, mesenchymal stem cell therapies, and molecular classification of cervical cancer. His leadership as a host in ongoing projects highlights his capabilities as a principal investigator.
Dr. Chunbo Li, Obstetrics and Gynecology Hospital of Fudan University, China

Profile

Scopus

🌱EARLY ACADEMIC PURSUITS

  • Dr. Li Chunbo began his illustrious academic journey at Fudan University, a top institution in China. He earned his Bachelor’s Degree in Clinical Medicine (2007-2012), laying the foundation for his medical expertise. This was followed by a Master’s Degree in Surgery (2012-2015), where he deepened his knowledge in surgical procedures and interventions. Dr. Li then pursued a PhD in Obstetrics and Gynecology (2018-2021), focusing on advanced research in women’s health. His academic background reflects a continuous pursuit of excellence and dedication to advancing medical science.

💼PROFESSIONAL ENDEAVORS

  • Dr. Li Chunbo has extensive professional experience, demonstrating his commitment to patient care and medical innovation. Since 2017, he has been an Attending Physician at the Affiliated Obstetrics and Gynecology Hospital of Fudan University, where he treats complex gynecological cases and contributes to cutting-edge research. Before this, he served as a Physician at the First Maternal and Infant Health Care Hospital of Tongji University from 2015 to 2017. His professional career highlights his dual focus on clinical excellence and academic advancement, benefiting both patients and the scientific community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Li has made remarkable contributions to the field of obstetrics and gynecology through his innovative research. His studies focus on the effects of PM2.5 exposure during pregnancy, examining its impact on mitochondrial imbalances and fetal growth. He has also explored pelvic organ prolapse and the therapeutic role of mesenchymal stem cells in tissue repair and inflammation regulation. In addition, Dr. Li is pioneering research into the molecular subtypes of cervical cancer, with the goal of developing targeted therapies tailored to the Chinese population. His work exemplifies the integration of clinical insight and scientific discovery.

🌍IMPACT AND INFLUENCE

  • Dr. Li Chunbo’s work has had a profound impact on both clinical practices and academic research. He has led significant projects, such as the Shanghai Youth Project, which investigates stem cell-based treatments for endometrial repair. His innovative approach has resulted in five high-impact publications in journals like Molecular Therapy – Nucleic Acids and Communications Biology. Furthermore, his dedication to advancing women’s health was recognized with the Shanghai “Medical Star” Talent Training Program Award in 2019. These achievements underscore his influence as a leader in gynecological and oncology research.

📜 ACADEMIC CITES 

  • Dr. Li’s research has gained widespread recognition within the academic community, as reflected in the numerous citations of his work. His single-cell transcriptomic studies have become key references in understanding the molecular and cellular mechanisms underlying cervical cancer. These contributions have not only enhanced academic discourse but also provided actionable insights for improving diagnosis and treatment strategies in clinical settings.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Li Chunbo’s legacy lies in his commitment to advancing medical science and improving patient outcomes. His ongoing research into targeted therapies for cervical cancer aims to revolutionize precision medicine in the Chinese population. Additionally, he is fostering collaboration between clinicians and researchers to integrate emerging technologies like single-cell transcriptomics into routine practice. Dr. Li also seeks to mentor the next generation of medical professionals, sharing his expertise to inspire innovation in obstetrics and gynecology. His forward-thinking approach ensures a lasting impact on the field and its future advancements.

📄Publications

  • Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes
    • Authors: Li, C.; Hua, K.
    • Journal: Frontiers in Immunology, 2024, 15, 1386072
  • Single-cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions
    • Authors: Li, C.; Hua, K.
    • Journal: Cancer Communications, 2023, 43(9), pp. 1055–1058
  • Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing
    • Authors: Li, C.; Liu, D.; Zhao, Y.; Ding, Y.; Hua, K.
    • Journal: Journal of Medical Virology, 2023, 95(6), e28857
  • Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
    • Authors: Ding, Y.; Zhang, X.; Qiu, J.; Li, C.; Hua, K.
    • Journal: Archives of Gynecology and Obstetrics, 2023, 307(6), pp. 1901–1909
  • Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis
    • Authors: Li, C.; Liu, D.; Yang, S.; Hua, K.
    • Journal: Frontiers in Immunology, 2022, 13, 966291

Yamin Zhang | Economics | Best Researcher Award

Published on by China Scientist

 Dr. Yamin Zhang | Economics | Best Researcher Award

Professional Skills:

  •  Proficient in advanced statistical tools (Stata, SPSS, Amos) and visualization techniques using software like CiteSpace and VOSviewer, showcasing a data-driven approach to research. Expertise in bibliometric analysis demonstrates her ability to synthesize and present comprehensive insights from complex datasets.
Dr. Yamin Zhang , Chinese Academy of Social Sciences, China

Profile

Scopus

🌱EARLY ACADEMIC PURSUITS

  • Dr. Yamin Zhang’s academic journey highlights a solid and diverse foundation in higher education. She began her studies with a Bachelor’s degree in Accounting from Henan University of Economics and Law, completed between 2012 and 2014. Building on this, she pursued a Master’s degree in Management Science and Engineering at Beijing Information Science and Technology University from 2015 to 2018, focusing on management theories and their applications. Her passion for understanding the dynamics of industrial development and societal management led her to Minzu University of China, where she earned a Doctoral degree in Industrial Society and Management (2020–2024). This academic trajectory reflects Dr. Zhang’s commitment to multidisciplinary learning and her dedication to addressing complex societal and economic challenges.

💼PROFESSIONAL ENDEAVORS

  • Dr. Zhang has actively participated in several influential projects and research initiatives throughout her career. She led an independent scientific research project at Minzu University of China, which explored the operational mechanisms and policies supporting floating populations’ entrepreneurial behavior in urbanized settings. Additionally, she contributed to projects funded by the Ministry of Education and the Beijing Social Science Foundation, examining senior management team dynamics, innovation, and the capability transitions of small enterprises. Her participation in Beijing University’s talent cultivation programs further underscores her professional involvement in fostering academic innovation and leadership. These endeavors demonstrate her ability to integrate theory with practice and her commitment to solving real-world problems.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhang’s research focuses on several critical and interrelated areas, including the coordinated development of regional economies, innovation and entrepreneurship within the floating population, and the impact of the digital economy on industrial growth. Her studies delve into the challenges faced by migrant entrepreneurs, the role of digital infrastructure in attracting high-skilled talent, and the mechanisms that drive economic synergy in regional development. By addressing these topics, Dr. Zhang contributes valuable insights into sustainable economic practices and the potential for innovation-driven growth in modern societies.

🌍IMPACT AND INFLUENCE

  • Dr. Zhang’s scholarly impact is evident in her array of high-quality publications in prestigious journals. She has co-authored significant works, including research on urban public services and their importance to immigrant entrepreneurs, published in Humanities and Social Sciences Communications (SSCI Q1, IF=3.7). Her work on top management team knowledge heterogeneity and its influence on financial performance appeared in Technological Forecasting and Social Change (SSCI Q1, IF=10.884). Additionally, her study on digital infrastructure’s role in talent attraction was featured in Economic Research Journal (CSSCI, IF=20.288). These publications not only highlight her expertise but also demonstrate her ability to produce research with both academic and practical relevance. Dr. Zhang has also presented her findings at notable conferences, including the Asia-Pacific Forum on Sustainable Development (2018) and Technological Forecasting and Social Change (2023), further amplifying her influence.

📜 ACADEMIC CITES 

  • Dr. Zhang’s proficiency in advanced data analysis tools, such as Stata, SPSS, CiteSpace, and VOSviewer, has enabled her to conduct robust bibliometric analyses. These tools allow her to map research trends and analyze complex datasets, underpinning the quality of her publications. Her technical expertise ensures her work is both methodologically sound and highly cited, reflecting the broader academic community’s recognition of her contributions to innovation, economics, and entrepreneurship studies.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Zhang’s dedication to advancing knowledge in her fields positions her as a leading thinker in coordinated economic development and digital innovation. Looking ahead, her forthcoming research on new transportation infrastructure and its impact on the inflow of highly educated entrepreneurial talent is expected to shape future policy and academic discussions. Her ability to combine theoretical insights with actionable strategies ensures her contributions remain influential and transformative. Dr. Zhang’s ongoing commitment to addressing societal challenges through her work promises to leave a lasting legacy in academia and beyond

📄Publications

  • what urban public services do immigrant entrepreneurs with different educational backgrounds most value?
    Authors: Cui, Y., Zhang, Y.
    Journal: Humanities and Social Sciences Communications, 2024, 11(1), 1553
  • The Impact of Urban Public Services on the Residence Intentions of Migrant Entrepreneurs in the Western Region of China
    Authors: Cui, Y., Zhang, Y.
    Journal: Sustainability (Switzerland), 2024, 16(3), 1229

Wei Zheng | Nuclear Medicine | Best Researcher Award

Published on by China Scientist

 Dr. Wei Zheng | Nuclear Medicine | Best Researcher Award

Research Contributions:

  • His work has enhanced the theoretical understanding of micromixers and provided practical, optimized solutions balancing efficiency and performance. This contributes to both academic knowledge and industry applications.
Dr. Wei Zheng , Tianjin Medical University General Hospital , China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Wei Zheng embarked on his academic journey with a deep passion for medical sciences. He laid a strong foundation by specializing in nuclear medicine, focusing on the study and treatment of thyroid-related disorders. His early education was marked by a commitment to mastering both the theoretical and practical facets of his field, which later became the cornerstone of his distinguished career.

💼PROFESSIONAL ENDEAVORS

  • Currently, Dr. Wei Zheng serves as the Chief Physician and Deputy Director of the Department of Nuclear Medicine at Tianjin Medical University General Hospital. In addition to his clinical responsibilities, He mentors postgraduate students as a Master’s Supervisor. Dr. Zheng is actively involved in several prestigious organizations, including the Chinese Association of Medical Imaging Technology, the Chinese Association of Nuclear Medicine Physicians, and the Therapeutics Group of the Chinese Society of Nuclear Medicine, where he contributes to the advancement of nuclear medicine practices.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zheng has made groundbreaking contributions in the diagnosis and treatment of thyroid-related disorders. His innovative work includes developing advanced therapies such as combining 131I with targeted drugs for iodine-refractory thyroid cancer and pioneering therapeutic strategies for Graves’ disease and ophthalmopathy. He has also spearheaded multicenter studies analyzing the effectiveness of 131I therapy in patients with lymph node and distant metastases, as well as in pediatric thyroid cancer cases. His research focuses on molecular imaging analysis using PET/MR and the pathogenesis of autoimmune thyroid disorders, aiming to advance both diagnosis and treatment.

🌍IMPACT AND INFLUENCE

  • Dr. Zheng’s research has profoundly influenced the field of nuclear medicine, particularly in the management and treatment of thyroid cancer and autoimmune thyroid diseases. His work has shaped clinical guidelines in China and expanded the global impact of radionuclide therapies. By integrating research findings into clinical practice, he has significantly improved patient outcomes and set a new standard for thyroid-related therapies.

📜 ACADEMIC CITES AND LEGACY

  • With an h-index of 15 and 548 citations to his name, Dr. Zheng’s scholarly work is widely recognized and respected. His research papers, published in leading journals, have been frequently cited, reflecting his substantial contributions to the academic and medical communities. Over the past three years, he has authored 14 influential articles as a first or corresponding author, demonstrating his continued commitment to advancing scientific knowledge.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Zheng’s innovative approaches and groundbreaking research have left a lasting impact on nuclear medicine. His efforts have advanced the understanding and treatment of thyroid disorders and autoimmune diseases, paving the way for new therapeutic strategies. As he continues his work, he is dedicated to mentoring young researchers and contributing to global advancements in medical science, ensuring his legacy as a pioneer in his field.

🏅 PROFESSIONAL MEMBERSHIPS 

  • Dr. Zheng is an active member and leader in numerous professional organizations. He serves as Director of the Chinese Association of Medical Imaging Technology, Vice Chairman of the Nuclear Medicine Branch of the Tianjin Association of Medical Imaging Technology, and a Standing Committee Member of the Chinese Association of Nuclear Medicine Physicians. Additionally, he holds editorial positions in esteemed journals, including the Chinese Journal of Nuclear Medicine and Molecular Imaging.

🌟 AWARDS AND RECOGNITION

  • Dr. Zheng’s exceptional achievements have earned his a nomination for the Best Researcher Award under the China Scientist Awards. His ability to blend clinical expertise with innovative research underscores his standing as a leading figure in nuclear medicine, inspiring peers and setting new benchmarks in the field.

📄Publications

  • Optimization and application of renal depth measurement method in the cadmium-zinc-telluride‑based SPECT/CT renal dynamic imaging
    • Authors: Zheng, H., Li, X., Wang, S., Jia, Q., Zheng, W.
    • Journal: EJNMMI Physics, 2024, 11(1), 96
  • Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma
    • Authors: Chai, J., Su, M., Zhang, R., Sun, H., Meng, Z.
    • Journal: BMC Cancer, 2024, 24(1), 816
  • Correction to: Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study
    • Authors: Yin, X., Lu, C., Sun, D., Tan, J., Zheng, W.
    • Journal: Endocrine, 2024, 86(2), pp. 863
  • Mouse model of Graves’ orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene
    • Authors: Wu, R., Li, N., Wang, X., Wang, R., Zheng, W.
    • Journal: Journal of Endocrinological Investigation, 2024, 47(10), pp. 2507–2519
  • Comparison of 131I therapeutic responses and clinical outcomes in patients with familial and sporadic differentiated thyroid cancer
    • Authors: Ji, Y., Wang, X., Li, X., Tan, J., Zheng, W.
    • Journal: Chinese Journal of Radiological Medicine and Protection, 2024, 44(6), pp. 531–536